Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Filings indexed 276 across all filing types
Latest filing 2025-05-08 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing a shipment of MDMA capsules to Australia, details on partnerships, regulatory approvals, and funding by Australia’s Department of Veterans’ Affairs. There are no financial results or report attachments, no shareholder vote or proxy materials, no board or management changes, no share issuance, and no detailed periodic financial statements. It is a general announcement of business activity and regulatory approval, which does not fit any specific category other than the fallback for miscellaneous regulatory or news announcements. Therefore, it should be classified as a Regulatory Filing (RNS).
2025-05-08 English
News release - English.pdf
Regulatory Filings
2025-05-05 English
Report of exempt distribution (45-106F1).pdf
Share Issue/Capital Change Classification · 85% confidence The document is a Form 45-106F1 “Report of Exempt Distribution” filed under Canadian securities rules to report an exempt distribution of shares (200,000 securities at $0.20 raising $40,000). It is not an annual or quarterly report, nor an earnings or management discussion. Rather, it documents a capital change via a share issuance. Thus it best fits the “Share Issue/Capital Change” category (SHA).
2025-03-21 English
Material change report - English.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a Canadian NI 51-102 Form 51-102F3 Material Change Report announcing the issuance of common shares (100,000 shares for advisory services and $20,000 of service fees settled by share issuance). This is an announcement of new share issues and a change to the company’s capital structure. Therefore, it fits the Share Issue/Capital Change category (SHA).
2025-03-21 English
News release - English.pdf
Regulatory Filings Classification · 70% confidence The document is a corporate press release providing operational updates (regulatory milestones, clinical trial progress, and market expansion) and also noting share issuances to advisors. It does not present financial results as an earnings release, nor is it an annual or interim report. It is not a financing round announcement per se, and the share issuance is incidental to services rather than fundraising. No specific investor presentation or governance document is attached. Therefore it does not fit specialized categories like 10-K, IR, ER, CAP, or PSI. It best fits the fallback “Regulatory Filings” category for general corporate announcements (RNS).
2025-03-12 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 78% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CFO under Canadian NI 52-109 for a venture issuer. It is not the interim financial report itself nor an announcement that a report is available; rather, it is a mandatory regulatory certification statement accompanying interim filings. No category explicitly matches a standalone certification other than a general regulatory filing. Therefore, it falls under the fallback Regulatory Filings category (RNS).
2025-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.